Key terms

About TECH

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest TECH news

Mar 22 7:02am ET Bio-Techne receives European IVDR certification for diagnostic test Feb 08 9:44am ET Alibaba downgraded, Disney upgraded: Wall Street’s top analyst calls Feb 08 7:01am ET Bio-Techne initiated with an Outperform at Scotiabank on market-leading growth Feb 07 4:19pm ET Bio-Techne initiated with an Outperform at Scotiabank Feb 05 4:05am ET Bio-Techne: Solid Consumables Business and Strategic Investments Anchor Buy Rating Amid Sector Headwinds Feb 02 9:37am ET Macy’s upgraded, New York Community downgraded: Wall Street’s top analyst calls Feb 02 8:50am ET Bio-Techne price target lowered to $85 from $88 at Deutsche Bank Feb 02 8:41am ET Bio-Techne price target lowered to $80 from $86 at Craig-Hallum Feb 02 7:40am ET Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), MoonLake Immunotherapeutics (MLTX) Feb 02 6:49am ET Bio-Techne price target raised to $73 from $68 at Baird Feb 02 6:38am ET Bio-Techne price target lowered to $87 from $92 at Stephens Feb 02 5:05am ET Bio-Techne Growth Outlook: Hold Rating Amidst Flat Growth and Valuation Concerns Feb 02 5:03am ET Bio-Techne downgraded to Hold from Buy at Stifel Feb 01 6:43am ET Bio-Techne reports Q2 adjusted EPS 40c, consensus 41c Jan 31 8:25pm ET Notable companies reporting before tomorrow’s open Jan 31 12:59pm ET Notable companies reporting before tomorrow’s open Jan 30 8:36pm ET Bio-Techne (TECH) Receives a Buy from Craig-Hallum Jan 26 8:46pm ET RBC Capital Sticks to Their Hold Rating for Bio-Techne (TECH) Jan 04 9:06am ET Bio-Techne named 2024 Top Pick at Argus

No recent news articles are available for TECH

No recent press releases are available for TECH

TECH Financials

1-year income & revenue

Key terms

TECH Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TECH Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms